Honeywell intends to take advantage of its Honeywell Forge and Sparta’s QMS offerings, to introduce new integrated solutions for life sciences industries. According to Honeywell, this acquisition will enable its customers to benefit from advanced digital QMS solutions to help them proactively achieve better quality including improved therapies, faster time to market, better business and patient outcomes, and effective regulatory compliance.
“Sparta’s TrackWise Digital® and QualityWise.aiSM are a welcome addition to Honeywell’s enterprise performance management software, Honeywell Forge, and will further enhance the link between quality and production data for life sciences manufacturers,” said Que Dallara, president and chief executive officer of Honeywell Connected Enterprise.
“Our combined offerings will make it easier for customers to gain critical insights from manufacturing and quality data that can improve their manufacturing processes while ensuring product quality, patient safety, and supply chain continuity.”
Headquartered in Hamilton, Sparta Systems has a total of about 250 employees globally and serves customers in areas such as pharma companies and medical device companies. Honeywell intends to leverage Sparta’s portfolio including its next-generation SaaS platform, to further strengthen its industrial automation services, digital transformation solutions and enterprise performance management software.
“Organizations need a quality management software solution with advanced digital capabilities that effectively automates, optimizes and standardizes quality processes across the board,” said Dana Jones, chief executive officer of Sparta Systems.
“When you combine Sparta’s leading QMS platform with Honeywell’s existing process automation and software offerings, you create a highly differentiated, comprehensive solution that allows customers to focus more on the value-add activities that will accelerate their growth.”
As announced, the acquisition is expected to close by the end of the first quarter of 2021, subject to certain regulatory approvals and other customary closing conditions.